Sofie-Yasmin Hassan
Overview
Explore the profile of Sofie-Yasmin Hassan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eshaq A, Flanagan T, Hassan S, Al Asheikh S, Al-Amoudi W, Santourlidis S, et al.
Cancers (Basel)
. 2024 Aug;
16(15).
PMID: 39123481
Protein tyrosine kinases (PTKs) function as key molecules in the signaling pathways in addition to their impact as a therapeutic target for the treatment of many human diseases, including cancer....
2.
Kharouf N, Flanagan T, Alamodi A, Al Hmada Y, Hassan S, Shalaby H, et al.
Cells
. 2024 Feb;
13(3.
PMID: 38334632
Melanoma frequently harbors genetic alterations in key molecules leading to the aberrant activation of PI3K and its downstream pathways. Although the role of PI3K/AKT/mTOR in melanoma progression and drug resistance...
3.
Al Hmada Y, Brodell R, Kharouf N, Flanagan T, Alamodi A, Hassan S, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38275910
Melanoma is the third most common type of skin cancer, characterized by its heterogeneity and propensity to metastasize to distant organs. Melanoma is a heterogeneous tumor, composed of genetically divergent...
4.
Kharouf N, Flanagan T, Hassan S, Shalaby H, Khabaz M, Hassan S, et al.
Cancers (Basel)
. 2023 Jun;
15(12).
PMID: 37370757
The role of the tumor microenvironment in tumor growth and therapy has recently attracted more attention in research and drug development. The ability of the microenvironment to trigger tumor maintenance,...
5.
Selimovic D, Kharouf N, Carrouel F, Hassan S, Flanagan T, Hassan S, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36982421
The antimicrobial protein S100A15 belongs to the S100 family, which is differentially expressed in a variety of normal and pathological tissues. Although the function of S100A15 protein has been discussed...
6.
El Jamal S, Alamodi A, Wahl R, Grada Z, Shareef M, Hassan S, et al.
Oncogene
. 2020 Jul;
39(32):5468-5478.
PMID: 32616888
Melanoma stem cells (MSCs) are characterized by their unique cell surface proteins and aberrant signaling pathways. These stemness properties are either in a causal or consequential relationship to melanoma progression,...
7.
Selimovic D, Wahl R, Ruiz E, Aslam R, Flanagan T, Hassan S, et al.
Int J Oncol
. 2019 Oct;
55(6):1324-1338.
PMID: 31638203
Head and neck squamous cell carcinoma (HNSCC) remains one of the most common malignancies worldwide. Although the treatment outcomes of HNSCC have improved in recent years, the prognosis of patients...
8.
El Jamal S, Grada Z, El Dinali M, Zhou H, Hassan S, Saad A, et al.
Lab Invest
. 2018 Nov;
99(4):539-550.
PMID: 30446717
Myocyte enhancer-binding factor 2B (MEF2B) has been implicated as a transcriptional regulator for BCL6. However, details about the interaction between MEF2B and BCL6 during expression, as well as the relationship...
9.
Alamodi A, Eshaq A, Hassan S, Al Hmada Y, El Jamal S, Fothan A, et al.
Histol Histopathol
. 2016 Jun;
31(12):1291-301.
PMID: 27301538
Human malignant melanoma is a highly aggressive skin tumor that is characterized by its extraordinary heterogeneity, propensity for dissemination to distant organs and resistance to cytotoxic agents. Although chemo- and...